MaxCyte STX Scalable Transfection System

Model: STX

Category: Cell Therapy and Regenerative Medicine

Booth No: M1017

Characteristic

With over 25 years of expertise, MaxCyte empowers scientists in cell therapy and protein production to achieve outstanding results. MaxCyte’s high-performance electroporation systems deliver efficient, precise, and low-toxicity transfection across a wide range of complex cell types, accelerating drug development and clinical timelines. Its scalable platform enables seamless transition from R&D to commercial manufacturing, supporting faster clinical translation. Gene-editing therapies utilizing MaxCyte technology have already received FDA approval, underscoring the platform’s proven value in advanced cell and gene therapies.
Key Features of MaxCyte:
1. Smart Operating System: Built-in Windows OS and touch-screen interface provide an intuitive, user-friendly experience that streamlines setup and improves lab productivity.
2. Multiple Cell Type and Preoptimized Protocol: Preloaded with over 70 optimized electroporation protocols covering a wide variety of cell types—including primary and hard-to-transfect cells—MaxCyte accelerates development for cell therapy, protein expression, and more.
3. Proprietary Electroporation Technology: Unique electrode design and universal electroporation buffer significantly enhance both cell viability and transfection efficiency, delivering consistent and reliable experimental outcomes.
4. Scalability: Linear scalability from small-scale RUO experiments to GMP-level manufacturing eliminates the need for re-optimization, saving valuable time and cost across the development pipeline.
5. Regulatory-Ready Platform: The world’s only electroporation platform with a US FDA Master File and full 21 CFR Part 11 compliance, MaxCyte is widely adopted in clinical trials for gene and cell therapy products.
6. Technical Support: MaxCyte’s expert support team offers customized transfection solutions and experimental optimization services to ensure clients overcome technical challenges and achieve research success.